安旭生物：股东减持股份计划公告

Core Points - Anxu Bio announced that shareholder Ma Huaxiang plans to reduce his holdings by up to 1,200,000 shares, which represents no more than 0.94% of the company's total share capital [1] - The reduction will occur through centralized bidding transactions and will not exceed 1.00% of the total shares within any consecutive 90-day period [1] - The share reduction period will commence 15 trading days after the announcement and will last for three months [1]